Patents by Inventor Samuel George Gibson

Samuel George Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-benzylindole-2-carboxamide derivatives
    Patent number: 7671080
    Abstract: The present invention relates to i-benzylindole-2-carboxamide derivatives of formula I, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 1-benzylindole-2-carboxamide derivatives and to their use in therapy, particularly for the treatment of obesity or nicotine dependence.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: March 2, 2010
    Assignee: N.V. Organon
    Inventors: Phillip Martin Cowley, Samuel George Gibson, Grant Wishart
  • Spiro(2H-1benzopyran-2,4?-piperidine) derivates as glycine transport inhibitors
    Patent number: 7507824
    Abstract: The present invention relates to spiro[2H-1-benzopyran-2,4?-piperidine] derivatives having general formula (I), or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said derivatives, as well as to the use of these spiro[2H-1-benzopyran-2,4?-piperidine] derivatives in therapy, more specifically for the treatment of CNS disorders.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: March 24, 2009
    Assignee: N.V. Organon
    Inventors: Samuel George Gibson, David John Miller
  • 1-Benzylindole-2-Carboxamide Derivatives
    Publication number: 20080280923
    Abstract: The present invention relates to i-benzylindole-2-carboxamide derivatives of formula I, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 1-benzylindole-2-carboxamide derivatives and to their use in therapy, particularly for the treatment of obesity or nicotine dependence.
    Type: Application
    Filed: March 17, 2006
    Publication date: November 13, 2008
    Applicant: N.V. Organon
    Inventors: Phillip Martin Cowley, Samuel George Gibson, Grant Wishart
  • Spiro(2H-1benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors
    Publication number: 20040029904
    Abstract: 1
    Type: Application
    Filed: August 8, 2003
    Publication date: February 12, 2004
    Inventors: Samuel George Gibson, David John Miller
  • Spiro(2h-1-benzopyran-2,4-piperidine)derivatives as glycine transport inhibitors
    Patent number: 6645973
    Abstract: The present invention relates to spiro[2H-1-benzopyran-2,4′-piperidine] derivatives having general formula (I), wherein the substituents R1, R2, X and Y are ase defined in the claims or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said derivatives, as well as to the use of these spiro[2H-1-benzopyran-2,4′-piperidine] derivatives in therapy, more specifically for the treatment of CNS disorders.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: November 11, 2003
    Assignee: Akzo Nobel
    Inventors: Samuel George Gibson, David John Miller
  • Piperidine derivatives for treating psychoses
    Patent number: 6288085
    Abstract: The present invention relates to certain novel piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: September 11, 2001
    Assignee: Akzo Nobel N.V.
    Inventors: Duncan Robertson Rae, Samuel George Gibson